You are here: Home » Markets » IPOs » Analysis
;
Business Standard

IPO Review: Advantage Advanced Enzyme

Niche play with robust growth potential should translate to higher earnings trajectory

Ram Prasad Sahu 

Advanced Enzyme Technologies, one of the largest enzyme makers in the world, is raising Rs 400 crore via an initial public offering (IPO), which is largely an offer for sale by promoters and other investors.

While only Rs 50 crore of the IPO is through fresh issue of shares, which will be used to repay debt at the company’s US subsidiary, there are reasons that make the IPO attractive including good business prospects, strong track record, niche limited competition segment the company operates in, higher entry barriers, and reasonable valuations. The company, which gets about ...

First Published: Mon, July 18 2016. 22:48 IST
RECOMMENDED FOR YOU